Back to top

medical: Archive

Zacks Equity Research

Philips' (PHG) Gets FDA Recall for Trilogy Ventilator Glitch

Philips' (PHG) software update for Trilogy Evo ventilators is set to mitigate a possible power malfunction and gets FDA Class I recall identification, as it may cause serious harm.

BSXPositive Net Change ECLPositive Net Change PHGPositive Net Change ALGNNegative Net Change

Zacks Equity Research

Here's Why You Should Retain Centene (CNC) Stock for Now

Centene (CNC) remains well-poised for growth on the back of sound growth in membership, divestitures and a growing cash balance.

ALCNegative Net Change CNCPositive Net Change EHCPositive Net Change BVSNegative Net Change

Zacks Equity Research

Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates

Theravance's (TBPH) first-quarter 2024 earnings beat estimates while revenues meet the same.

TBPHNegative Net Change VTRSNegative Net Change THRDNegative Net Change

Zacks Equity Research

QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus

QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.

RMDNegative Net Change QGENNegative Net Change HIMSPositive Net Change HITINegative Net Change

Zacks Equity Research

Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals

Novo Nordisk's (NVO) shares rise 3.1% as the company meets co-primary endpoints in a late-stage study evaluating its investigational candidate, Mim8, for the treatment of haemophilia A.

NVONegative Net Change LGNDPositive Net Change ANIPNegative Net Change ANVSPositive Net Change

Zacks Equity Research

Company News For May 14, 2024

Companies In The Article Are:SQSP,INCY, WBA and GOOG.

GOOGPositive Net Change INCYPositive Net Change WBANegative Net Change SQSPPositive Net Change

Zacks Equity Research

Bayer (BAYRY) Q1 Earnings Fall Y/Y on Lower Product Sales

Bayer's (BAYRY) Q1 earnings and sales decline year over year due to a fall in volumes for non-glyphosate-based herbicides and lower prices for glyphosate-based products in the Crop Science division.

REGNPositive Net Change JNJPositive Net Change BAYRYPositive Net Change LGNDPositive Net Change

Zacks Equity Research

Reasons to Add The Cooper Companies (COO) to Your Portfolio

The Cooper Companies (COO) benefits from strength in its business segments. Its acquisitions are likely to drive the top line. A rise in selling, general and administrative expenses is, however, concerning.

DVAPositive Net Change ALGNNegative Net Change COONegative Net Change MEDPPositive Net Change

Zacks Equity Research

Zacks.com featured highlights Medpace, American Axle, Diebold Nixdorf, Euronet and Omnicom

Medpace, American Axle, Diebold Nixdorf, Euronet and Omnicom have been highlighted in this Screen of The Week article.

OMCNegative Net Change AXLPositive Net Change DBDPositive Net Change EEFTPositive Net Change MEDPPositive Net Change

Shaun Pruitt

2 Intriguing Medical Stocks to Buy for Steady Growth as Earnings Approach

Among the medical sector, Alcon (ALC) and Prestige Consumer Healthcare (PBH) are two intriguing stocks to buy for growth as their quarterly results approach on Tuesday, May 14.

ALCNegative Net Change PBHNegative Net Change

Zacks Equity Research

Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal

Novavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19-influenza combination vaccines. This announcement even overshadows the dismal Q1 results.

SNYNegative Net Change PFENegative Net Change MRNAPositive Net Change NVAXNegative Net Change

Sheraz Mian

Top Analyst Reports for Boston Scientific, Arista Networks & Palo Alto Networks

Today's Research Daily features new research reports on 16 major stocks, including Boston Scientific Corporation (BSX), Arista Networks, Inc. (ANET) and Palo Alto Networks, Inc. (PANW).

BSXPositive Net Change AEPPositive Net Change CBOEPositive Net Change HCAPositive Net Change PANWPositive Net Change ANETNegative Net Change

Zacks Equity Research

QIAGEN (QGEN) to Enhance Forensics With New Partnership

QIAGEN's (QGEN) recent deal advances a novel test for its QIAcuity digital PCR devices. This will enhance forensics by improving the quantification of DNA in human samples.

RMDNegative Net Change QGENNegative Net Change MEDPPositive Net Change EHCPositive Net Change

Zacks Equity Research

Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio

Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.

BSXPositive Net Change ECLPositive Net Change ISRGPositive Net Change ALGNNegative Net Change

Zacks Equity Research

Three Reasons to Retain Integer Holdings (ITGR) Stock for Now

Integer Holdings' (ITGR) research and product development activities raise optimism about the stock.

ECLPositive Net Change DVAPositive Net Change VEEVPositive Net Change ITGRPositive Net Change

Zacks Equity Research

Catalent's (CTLT) Latest Partnership to Boost Clinical Trials

Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.

ECLPositive Net Change DVAPositive Net Change VEEVPositive Net Change CTLTPositive Net Change

Zacks Equity Research

Orthofix Medical's (OFIX) Telescopic Nail Gets FDA Clearance

Orthofix Medical (OFIX) announces the FDA clearance of its Rodeo Telescopic Nail, which is likely to aid in curing fractures or abnormalities in individuals with osteogenesis imperfecta.

BSXPositive Net Change ECLPositive Net Change OFIXNegative Net Change ALGNNegative Net Change

Zacks Equity Research

Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study

Bristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails to meet the primary endpoint of progression-free survival in unresectable stage III NSCLC.

AZNNegative Net Change BMYNegative Net Change MRKPositive Net Change LGNDPositive Net Change

Zacks Equity Research

Insulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised

Insulet's (PODD) first-quarter performance benefits from the continued high demand for Omnipod 5.

RMDNegative Net Change PODDPositive Net Change MEDPPositive Net Change EHCPositive Net Change

Zacks Equity Research

Company News For May 13, 2024

Companies In The Article Are:NVAX, SNY, MRNA, G and IAG.

SNYNegative Net Change MRNAPositive Net Change GNegative Net Change NVAXNegative Net Change IAGPositive Net Change

Nalak Das

U.S. Consumer Sentiment Plummets in May: 5 Safe Stock Picks

We have narrowed our search to five defensive stocks with strong potential for the rest of 2024. These are: ES, ATO, MKC, TSN, RMD.

RMDNegative Net Change TSNNegative Net Change MKCNegative Net Change ATOPositive Net Change ESNegative Net Change

Zacks Equity Research

Teleflex (TFX) Expands Vascular Access Portfolio With New Launch

Teleflex (TFX) debuts the new Arrow EZ-IO Intraosseous Access Procedure Tray.

RMDNegative Net Change TFXNegative Net Change HIMSPositive Net Change HITINegative Net Change

Swayta Shah

5 Stocks With Upgraded Broker Ratings Worth Investing in Now

Brokers have deeper insights into stocks and macroeconomic factors. So, one should follow broker rating upgrades to pick stocks like Medpace (MEDP), American Axle & Manufacturing (AXL), Diebold Nixdorf (DBD), Euronet (EEFT) and Omnicom (OMC).

OMCNegative Net Change AXLPositive Net Change DBDPositive Net Change EEFTPositive Net Change MEDPPositive Net Change

Zacks Equity Research

Best Value Stocks to Buy for May 13th

OGN, ODP and ASC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 13, 2024.

ODPNegative Net Change COOPPositive Net Change OGNPositive Net Change

Zacks Equity Research

Zacks.com featured highlights Hasbro, Brinker International, DaVita, Leidos Holdings and Allstate

Hasbro, Brinker International, DaVita, Leidos Holdings and Allstate have been highlighted in this Screen of The Week article.

HASPositive Net Change DVAPositive Net Change EATNegative Net Change ALLPositive Net Change LDOSPositive Net Change